Srovnání vaginálního užití mikronizovaného progesteronu k luteální podpoře. Randomizovaná studie porovnávající Utrogestan a Crinone 8
[Comparison of vaginal use of micronized progesterone for the luteal support. Randomized study comparison of Utrogestan and Crinone 8]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články, randomizované kontrolované studie
PubMed
28252308
PII: 60463
- Klíčová slova
- luteal phase support IVF/ET.,
- MeSH
- aplikace intravaginální MeSH
- dospělí MeSH
- fertilizace in vitro * MeSH
- intracytoplazmatické injekce spermie * MeSH
- lidé MeSH
- luteální fáze MeSH
- přenos embrya * MeSH
- progesteron analogy a deriváty terapeutické užití MeSH
- progestiny terapeutické užití MeSH
- prospektivní studie MeSH
- těhotenství MeSH
- úhrn těhotenství na počet žen v reprodukčním věku * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- Crinone MeSH Prohlížeč
- progesteron MeSH
- progestiny MeSH
OBJECTIVE: The study was focused on comparison of efficiency, safety and tolerance of vaginal use of micronized progesterone in preparations Utrogestan and Crinone 8%. DESIGN: Prospective randomized study. SETTING: Department of Gynecology and Obstetric, University Hospital, Olomouc, Faculty of Medicine and Dentistry, Palacky University, Olomouc. MATERIAL AND METHODOLOGY: Into a prospective randomized study was, after calculation of 80% of the power of the study, α = 0,05, included 111 women in age between 18-40 with a basal value FSH < 10 IU/l and a normal finding in uteral cavity. After evaluation of efficiency of both preparations there was selected a fertilization rate, an implantation rate, a pregnancy rate and a take-home baby rate. Comparison of tolerance was made from evaluation of 21 parameters which were obtained through a questionnaire. RESULTS: There were not been proven any significant differences in efficiency between both preparations. Crinone 8% was in patients better tolerated. CONCLUSION: Luteal support within the IVF/ICSI-ET remains an integral part of the treatment. According to the outcomes of the study it seems to be more suitable to use a vaginal gel for the luteal support with micronized progesterone.